Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner

被引:12
作者
Cho, Chia-Fong [1 ,2 ]
Chen, Po-Ku [1 ,2 ]
Chang, Po-Chiao [1 ]
Wu, Hau-Lin [1 ,2 ]
Shi, Guey-Yueh [1 ,2 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan
关键词
Angiogenesis; Kringle; 1-5; Protein kinase A; Thrombomodulin; PROSTATE CARCINOMA-CELLS; LECTIN-LIKE DOMAIN; ENDOTHELIAL-CELLS; ANGIOSTATIN GENERATION; URINARY ANGIOSTATIN; CANCER; EXPRESSION; ENDOCYTOSIS; ACTIVATION; THROMBIN;
D O I
10.1016/j.yjmcc.2013.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kringle 1-5 (K1-5), an endogenous proteolytic fragment of human plasminogen (Plg), is an angiostatin-related protein that inhibits angiogenesis. Many angiostatin-related proteins have been identified, but the detailed molecular mechanisms underlying their antiangiogenic effects remain unclear. Thrombomodulin (TM) is a transmembrane glycoprotein that plays a major role in the anticoagulation process in endothelial cells. Previously, we demonstrated that recombinant TM could interact with Pig to enhance Plg activation. In the present study, we investigated the interaction between TM and K1-5, and their functions in endothelial cells. We found that K1-5 colocalized with TM and directly interacted with TM through the TM lectin-like domain. After K1-5 interacted with TM, it induced TM internalization and degradation. In addition, the K1-5-induced TM internalization and degradation in proteasomes after ubiquitin modification were dependent on protein kinase A (PKA). Moreover, a PKA-specific inhibitor reversed the effects of K1-5 on cell migration and tube formation. Consistent with these findings, TM overexpression resulted in increased cell migration; moreover, K1-5 inhibited the increase of TM-mediated cell migration in a PKA-dependent manner. We determined that TM acts as a K1-5 receptor and that K1-5 induces TM internalization, ubiquitination, and degradation through the PKA pathway, by which K1-5 may inhibit endothelial cell migration and tube formation. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 40 条
[1]   Angiostatin and matrix metalloprotease expression following ischemic acute renal failure [J].
Basile, DP ;
Fredrich, K ;
Weihrauch, D ;
Hattan, N ;
Chilian, WM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (05) :F893-F902
[2]   Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis [J].
Cao, RH ;
Wu, HL ;
Veitonmäki, N ;
Linden, P ;
Farnebo, J ;
Shi, GY ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5728-5733
[3]  
Chen JS, 2010, ARCH PATHOL LAB MED, V134, P1804, DOI 10.1043/2009-0490-OAR.1
[4]   THROMBOMODULIN LACKING THE CYTOPLASMIC DOMAIN EFFICIENTLY INTERNALIZES THROMBIN VIA NONCLATHRIN-COATED, PIT-MEDIATED ENDOCYTOSIS [J].
CONWAY, EM ;
NOWAKOWSKI, B ;
STEINERMOSONYI, M .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 158 (02) :285-298
[5]   TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS [J].
CONWAY, EM ;
ROSENBERG, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5588-5592
[6]   Ezrin is a cyclic AMP-dependent protein kinase anchoring protein [J].
Dransfield, DT ;
Bradford, AJ ;
Smith, J ;
Martin, M ;
Roy, C ;
Mangeat, PH ;
Goldenring, JR .
EMBO JOURNAL, 1997, 16 (01) :35-43
[7]   Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer [J].
Drenberg, Christina D. ;
Saunders, Beatriz O. ;
Wilbanks, George D. ;
Chen, Ren ;
Nicosia, Roberto F. ;
Kruk, Patricia A. ;
Nicosia, Santo V. .
GYNECOLOGIC ONCOLOGY, 2010, 117 (01) :117-124
[8]   THE REGULATION OF NATURAL ANTICOAGULANT PATHWAYS [J].
ESMON, CT .
SCIENCE, 1987, 235 (4794) :1348-1352
[9]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[10]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31